The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

• Status: Completed
• Trial end date: 2004-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate clinical safety and effect of Omega-3 fat oil emulsion on outcome in post-operative cancer patients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sino-Swed Pharmaceutical Corporation
• Treatments: Soybean oil, phospholipid emulsion

Criteria

Inclusion Criteria:

• Post-operative male and female cancer patients

• Require post operative parenteral nutrition support at least 7 days based on nutritional risk screening(BMI 20-25)

• Sign an informed consent

Exclusion Criteria:

• Diabetes Mellitus

• Abnormal fatty metabolism (TG>200mg/dl or cholesterol>240mg/dl )

• Renal dysfunction (Cr>1.6mg/dl or BUN>30mg/dl)

• Liver dysfunction (ALT>60U/L or TBIL>1.2mg/dl)

• Lienectomy

• Temperature>37.5°C

• Undergoing hormone therapy

• Pregnancy